Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 6:50 PM View:  | Gilead Sciences Inc 10% Owner | Xilio Therapeutics, Inc. (XLO) | 02-Apr-24 | Private Purchase | 485,250 | $0.76 | $368,790.00 | 7% 6.86M to 7.35M | |
| 09-Feb-24 4:33 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 08-Feb-24 | Sale | 733 | $0.64 | $469.12 | (< 1%) 2.76M to 2.75M | |
| 09-Feb-24 4:33 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 08-Feb-24 | Sale | 267 | $0.64 | $170.88 | (< 1%) 2.75M to 2.75M | |
| 16-Jan-24 6:16 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 12-Jan-24 | Sale | 560 | $0.83 | $464.80 | (< 1%) 2.76M to 2.76M | |
| 16-Jan-24 6:16 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 12-Jan-24 | Sale | 1,540 | $0.83 | $1,278.20 | (< 1%) 2.76M to 2.76M | |
| 16-Jan-24 6:16 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 11-Jan-24 | Sale | 1,566 | $0.87 | $1,362.42 | (< 1%) 2.76M to 2.76M | |
| 16-Jan-24 6:16 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 11-Jan-24 | Sale | 569 | $0.87 | $495.03 | (< 1%) 2.76M to 2.76M | |
| 10-Dec-21 8:33 PM View: | Bain Capital Life Sciences ... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 10-Dec-21 | Market Purchase | 25,000 | $9.65 | $241,202.00 | < 1% 2.78M to 2.81M | 3% |
| 10-Dec-21 8:33 PM View: | Bain Capital Life Sciences ... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 09-Dec-21 | Market Purchase | 4,011 | $9.84 | $39,485.10 | < 1% 2.78M to 2.78M | < 1% |
| 10-Dec-21 8:33 PM View: | Bain Capital Life Sciences ... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 08-Dec-21 | Market Purchase | 13,458 | $9.62 | $129,474.00 | < 1% 2.76M to 2.78M | 3% |
| 28-Oct-21 12:55 PM View: | Sv7 Impact Medicine Fund Lp 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 302,588 | -- | -- | 15% 2.0M to 2.3M | |
| 26-Oct-21 5:30 PM View: | Rivervest Venture Fund Iv, ... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 250,000 | $16.00 | $4,000,000.00 | 10% 2.38M to 2.63M | |
| 26-Oct-21 5:02 PM View: | Bay City Capital LLC 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 816,990 | -- | -- | 100% 0 to 816.99K | |
| 26-Oct-21 5:04 PM View: | Rock Springs Capital Manage... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 907,766 | -- | -- | 100% 0 to 907.77K | |
| 28-Oct-21 7:15 PM View: | Flynn James E 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 775,000 | $16.00 | $12,400,000.00 | 51% 1.51M to 2.29M | |
| 28-Oct-21 3:45 PM View: | Fmr Corp | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 1,881,360 | -- | -- | 3575% 52.62K to 1.93M | |
| 28-Oct-21 12:55 PM View: | Sv7 Impact Medicine Fund Lp 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 998,544 | -- | -- | 100% 0 to 998.54K | |
| 28-Oct-21 12:55 PM View: | Sv7 Impact Medicine Fund Lp 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 302,588 | -- | -- | 13% 2.3M to 2.6M | |
| 26-Oct-21 5:01 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 2,545,530 | -- | -- | 9673% 26.31K to 2.57M | |
| 26-Oct-21 5:02 PM View: | Bay City Capital LLC 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 312,500 | $16.00 | $5,000,000.00 | 38% 816.99K to 1.13M | |
| 26-Oct-21 5:04 PM View: | Rock Springs Capital Manage... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 500,000 | $16.00 | $8,000,000.00 | 55% 907.77K to 1.41M | |
| 26-Oct-21 8:31 PM View: | Takeda Pharmaceutical Co Ltd 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 1,475,120 | -- | -- | 100% 0 to 1.48M | |
| 28-Oct-21 3:57 PM View: | Fil Ltd | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 218,705 | -- | -- | 100% 0 to 218.71K | |
| 28-Oct-21 12:55 PM View: | Sv7 Impact Medicine Fund Lp 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 998,544 | -- | -- | 100% 998.55K to 2.0M | |
| 26-Oct-21 5:30 PM View: | Rivervest Venture Fund Iv, ... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 1,191,440 | -- | -- | 100% 1.19M to 2.38M | |
| 26-Oct-21 5:01 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 187,500 | $16.00 | $3,000,000.00 | 7% 2.57M to 2.76M | |
| 26-Oct-21 5:06 PM View: | Merck Kgaa 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 680,825 | -- | -- | 100% 0 to 680.83K | |
| 28-Oct-21 7:15 PM View: | Flynn James E 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 1,512,940 | -- | -- | 100% 0 to 1.51M | |
| 26-Oct-21 4:51 PM View: | Alexandria Venture Investme... 10% Owner | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 166,423 | -- | -- | 100% 0 to 166.42K |
